Frontiers in Cardiovascular Science Archived Talks


2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014

The Future of Angiogenesis for the Treatment of Coronary Disease: A Historical Perspective

Frank W. Sellke, MD
Karl E. Karlson, MD and Gloria A. Karlson Professor of Cardiothoracic Surgery; Professor of Surgery Chief, Division of Cardiothoracic Surgery; Brown Medical School and Lifespan Hospitals

December 5, 2017


Mechanism and Therapy for Cerebral Cavernous Malformation

Mark L. Kahn, MD
Professor of Medicine, University of Pennsylvania

November 28, 2017

Heart Failure: Two Inflammatory Tales

Joseph A. Hill, MD, PhD
James T. Willerson, M.D., Distinguished Chair in Cardiovascular Diseases; Frank M. Ryburn Jr. Chair in Heart Research; Chief of Cardiology, UT Southwestern

November 21, 2017


Modeling Cardiovascular Development with Human Pluripotent Stem Cells

Gordon Keller, PhD
Director, McEwen Centre for Regenerative Medicine Senior Scientist, Ontario Cancer Institute
Toronto General and Western Hospital, Toronto, Canada

November 7, 2017

Gut Microbiota as Treatment Target for Cardio-Renal Risks

Wilson Tang, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University

October 31, 2017


Stanford + Takeda: Alliance for Innovative Medicines

Chaitan Khosla, PhD and Juan Harrison, Takeda

Khosla: Wells H. Rauser and Harold M. Petiprin Professor in the School of Engineering and Professor of Chemistry and, by courtesy, of Biochemistry

Harrison: Vice-President, Center for External Innovation, Takeda

October 24, 2017


Evidence-based Medicine: Precisely

John P. A. Ioannidis
C. F. Rehnborg Professor in Disease Prevention in the School of Medicine and Professor of Health Research and Policy (Epidemiology) and, by courtesy, of Statistics and of Biomedical Data Science

October 17, 2017


Signalosomes – Nodal Regulators and Therapeutic Targets for Heart Failure

Michael Kapiloff, MD, PhD
Associate Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)

October 10, 2017


A Layperson’s Involvement in Fighting CVD and Stroke

Alvin L. Royse, JD
Immediate Past Chairman of American Heart Association, Councilman Town of Hillsborough, Retired Senior Partner Deloitt & Touche LLPx

September 12, 2017

The Natriuretic Peptides and Cardiometabolic Disease: From Base Pairs to Bedside

Thomas J. Wang, MD
Gottlieb C. Friesinger II Professor of Medicine; Director, Division of Cardiovascular Medicine; Physician-in-Chief, Vanderbilt Heart and Vascular Institute

May 16, 2017


Therapeutic Targeting of Cardiac (and Kidney) Fibrosis

Burns C. Blaxall, PhD, FAHA, FACC, FAPS
Director of Translational Science, Heart Institute Co-Director, Heart Institute Research Core & Biorepository Professor, UC Department of Pediatrics, University of Cincinnati

April 18, 2017


Renal Denervation in Heart Failure

David J. Lefer, PhD
Director, Cardiovascular Center of Excellence Professor of Pharmacology, LSU Health New Orleans

April 11, 2017


Beyond Biopsy: Using Genomics to Quantify Transplant Outcomes

Hannah Valantine, MD, MRCP
Hannah Valantine, MD, MRCP, Senior Investigator Laboratory of Tranplantation Genomics, NHLBI NIH Chief Officer for Scientific Workforce Diversity

March 21, 2017

Precision Medicine in PAH

Vinicio de Jesus Perez, MD
Assistant Professor of Medicine (Pulmonary and Critical Care Medicine)

March 7, 2017

The Flipside of Oxidative Stress: The World of Reductive Stress

Ivor Benjamin, MD
Ivor Benjamin, MD, Director, Cardiovascular Center Professor, Department of Medicine Division of Cardiology, Medical College of Wisconsin

February 21, 2017

Introduction to the Stanford Human Immune Monitoring Center

Holden Terry Maecker, PhD
Associate Professor (Research) of Microbiology and Immunology, Stanford

February 14, 2017

Rebuilding the Failing Heart with Cell Therapy: Roadblocks to Overcome

Jianyi "Jay" Zhang, MD, PhD
Chair, Department of Biomedical Engineering T. Michael and Gillian Goodrich Endowed Chair of Engineering Leadership Professor of Medicine, of Engineering School of Medicine, School of Engineering, The University of Alabama Birmingham

January 31, 2017


Pathophysiologic Implications of Peripheral Artery Disease: It’s About Life and Limb

Mark A. Creager, MD
Director, Heart and Vascular Center, Dartmouth-Hitchcock Medical Center Professor of Medicine, Geisel School of Medicine at Dartmouth

January 24, 2017


Role of MG53 in Metabolic Syndrome and Diabetic Cardiomyopathy

Rui-Ping Xiao, MD, PhD
Professor at the Institute of Molecular Medicine, Peking University, Beijing, China

January 17, 2017